Money
Switchpoint Bio Secures €4.75 Million for Epigenomic Platform
Switchpoint Bio has raised €4.75 million to scale its blood-based epigenomic platform designed to analyze disease progression and drug response.
November 11, 2026, 11:14 AM·EU-Startups
